Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
613.00    6.00 (0.99%)
Bid:
610.00
Ask:
612.00
Spread: 2.00 (0.328%)
Market Cap: £680.28m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Takeover Panel deadline imposed under Rule 12.2

9 Jul 2013 07:03

RNS Number : 8792I
Takeover Panel
09 July 2013
 

2013/8

BRITVIC PLC ("BRITVIC")

A.G. BARR PLC ("A.G. BARR")

The Panel Executive has been considering the application of Rule 12.2 of the Code to the proposed acquisition by A.G. Barr of Britvic. Following discussions with both parties' advisers and the announcement by the Competition Commission that it has formally cleared the proposed acquisition, the Panel Executive has ruled that A.G. Barr must, by 5.00 p.m. on Tuesday, 30 July 2013, either announce a firm intention to make an offer for Britvic under Rule 2.7 or announce that it does not intend to make an offer for Britvic. This deadline is capable of extension only with the consent of the Panel Executive. In the event that A.G. Barr announces that it does not intend to make an offer for Britvic, A.G. Barr, and persons acting in concert with it, will be bound by the restrictions contained in Rule 2.8 for six months from the date of such announcement.

 Each of the parties has accepted this ruling.

 

9 July 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUKRNROAABRRR
Date   Source Headline
2nd Aug 20177:00 amRNSTrading Update
28th Jul 20175:00 pmRNSClose period repurchase programme
26th Jul 20177:00 amRNSTransaction in Own Shares
25th Jul 20171:45 pmRNSDirector/PDMR Shareholding
25th Jul 20177:00 amRNSTransaction in Own Shares
24th Jul 20171:37 pmRNSDirector/PDMR Shareholding
17th Jul 20178:09 amRNSTransaction in Own Shares
14th Jul 20177:43 amRNSTransaction in Own Shares
13th Jul 201710:07 amRNSNotice of Trading Update
10th Jul 20172:21 pmRNSDirector/PDMR Shareholding
28th Jun 20177:13 amRNSTransaction in Own Shares
27th Jun 201712:14 pmRNSTransaction in Own Shares
14th Jun 20173:25 pmRNSDirector/PDMR Shareholding
14th Jun 20177:00 amRNSTransaction in Own Shares
13th Jun 20177:14 amRNSTransaction in Own Shares
12th Jun 20171:33 pmRNSDirector/PDMR Shareholding
12th Jun 20171:32 pmRNSDirector/PDMR Shareholding
12th Jun 20171:30 pmRNSDirector/PDMR Shareholding
12th Jun 20171:28 pmRNSDirector/PDMR Shareholding
8th Jun 20172:02 pmRNSDirector/PDMR Shareholding
6th Jun 20174:04 pmRNSDirector/PDMR Shareholding
31st May 201712:38 pmRNSAGM Statement
18th May 20177:00 amRNSTransaction in Own Shares
9th May 20171:20 pmRNSDirector/PDMR Shareholding
3rd May 20179:43 amRNSDirector/PDMR Shareholding
27th Apr 20174:08 pmRNSAnnual Report and Accounts and Notice of AGM
26th Apr 201712:17 pmRNSDirector/PDMR Shareholding
10th Apr 201712:12 pmRNSDirector/PDMR Shareholding
3rd Apr 20173:47 pmRNSDirector/PDMR Shareholding
28th Mar 20177:00 amRNSFinal Results
8th Mar 20172:49 pmRNSDirector/PDMR Shareholding
1st Mar 20177:00 amRNSFurther reduction of sugar across portfolio
8th Feb 20171:34 pmRNSDirector/PDMR Shareholding
1st Feb 20177:00 amRNSTrading Update
12th Jan 20177:00 amRNSNotice of Trading Update
10th Jan 20172:10 pmRNSDirector/PDMR Shareholding
9th Jan 20174:35 pmRNSPrice Monitoring Extension
9th Jan 20172:56 pmRNSDirector Declaration
13th Dec 20167:00 amRNSAnalyst Site Visit
8th Dec 201612:42 pmRNSDirector/PDMR Shareholding
14th Nov 201611:23 amRNSHolding(s) in Company
10th Nov 20162:59 pmRNSHolding(s) in Company
8th Nov 201612:42 pmRNSDirector/PDMR Shareholding
25th Oct 201611:33 amRNSDirector/PDMR Shareholding
25th Oct 201611:20 amRNSDirector/PDMR Shareholding
25th Oct 201611:19 amRNSDirector/PDMR Shareholding
25th Oct 201611:13 amRNSDirector/PDMR Shareholding
10th Oct 20161:27 pmRNSDirector/PDMR Shareholding
28th Sep 20162:13 pmRNSCorrection: Interim Results
27th Sep 20167:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.